Medidata Leverages Big Data and Cloud Platform to Reduce Clinical Trial Costs
On March 10, Medidata Solutions announced a mobile health collaborative research partnership with Nestlé in China to evaluate the impact of nutritional supplements and exercise on the physical health of older adults. The study will reportedly utilize trackers and mobile applications from Garmin, the world’s fourth-largest wearable device manufacturer, for monitoring purposes.
Medidata has been dedicated to providing cloud-based development solutions for the life sciences, revolutionizing the landscape of clinical trials through intelligent data analytics. What sets the Medidata Clinical Cloud apart? How has Medidata Solutions, Inc. managed to stand out in this era defined by “data”? Let VCBeat’s editor explain it all for you.
Launch Clinical Trials in Collaboration with Nestlé
In May 2015, the Nestlé Research Center, a subsidiary of Nestlé, initiated a clinical trial investigating the combination of a nutritional product with a specific exercise regimen. All study participants were required to wear Garmin vívofit activity trackers to collect data on their physical activity and daily movements. Additionally, participants used Medidata’s patient electronic record software to complete questionnaires regarding quality of life and other metrics via smartphones or tablets. Monitoring data from the Garmin activity trackers and daily self-reported data from Patient Cloud were all imported into the Medidata Clinical Cloud platform. Medidata Clinical Cloud then integrated all received data, performing real-time recording, analysis, and summarization to gain insights into participant behaviors, treatment outcomes, and other relevant factors.
Mr. Mike Capone, Chief Operating Officer of Medidata, stated, “We have been committed to advancing the application of mobile health tools in highly structured clinical trials, and we believe this will bring significant value to scientific research initiatives. This exciting collaboration with Nestlé is part of our ongoing efforts. Wearable devices, sensors, and applications collect real-time data from study participants while providing a comprehensive view of their daily activities, physical condition, and well-being. We are immensely proud of this mobile health platform, as it enables Nestlé to provide nutritional support to individuals, thereby helping them lead healthier and happier lives.”
Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York City, USA, with branches currently established in the United Kingdom and Japan. Medidata provides an advanced service platform that reduces the cost of clinical trials by offering cost-effective clinical research services in areas such as study design, trial budgeting, site negotiation, trial optimization, randomization and trial supply management, clinical data capture and management, safety event collection, medical coding, and clinical business analytics. Meanwhile, Medidata has accumulated extensive client resources and information, including biopharmaceutical companies, medical device and diagnostic companies, academic institutions, and many of the top 25 global pharmaceutical companies.
Core Services: Medidata Clinical Cloud
Today, the healthcare industry faces pressure from patent expirations and urgently needs novel, improved therapeutic approaches. A critical component in this process is clinical trials, as they play a decisive role in determining the efficacy and safety of final medical products and services. However, conducting clinical trials is typically complex and costly. Medidata Clinical Cloud is a unique, vertically oriented software-as-a-service (SaaS) platform that directly provides clinical research services to life sciences companies and patients in need. It serves both small biotechnology firms and large pharmaceutical companies, which rely heavily on it. This is because Medidata Clinical Cloud offers:
Reducing Clinical Trial Costs
Reducing the Risk of Medical Malpractice
Accelerate the market launch of drugs and medical devices
To date, the Medidata Clinical Cloud has collected medical data from over 2 million patients (approximately 8 billion records) across more than 9,000 studies, with over half of this data being updated daily.
AppConnect—The Companion App for Clinical Cloud
AppConnect is an app that complements the Medidata Clinical Cloud, designed for individuals without professional clinical trial expertise. After downloading the app, users can access comprehensive instructional tools and videos on the mhealth.works website, enabling anyone to set up their own dedicated laboratory on their mobile phone. This laboratory offers the following capabilities:
Freely collect and process data from any app
When processing terminal data streams, app developers can construct mobile front-end data.
Seamlessly compatible with the ResearchKit framework and other third-party tools
SensorLink: Wearable Data Sensors Integrated with Medidata Clinical Cloud
SensorLink is capable of:
Mastering Data from Over 200 Sensors
Visualization and analytics dashboard to view patient compliance and data quality
Provide data visualization and analytics dashboards to better assess patient compliance and data quality
Highly scalable, secure infrastructure and tools
Ensure Quantifiable Security Infrastructure and Tools
Medidata's Electronic Patient-Reported Outcomes Application—ePRO
ePRO seamlessly integrates with Medidata Clinical in clinical trials, as it enables:
Compatible with Android and iOS systems
Supports the most commonly used questionnaire models for 19 of the top 20 global healthcare companies
Provide configurable text and quantified questions without the need to obtain user background information.
Medidatabusiness cooperation
Medidata Collaborates with Shanghai Henlius Biotech to Optimize Phase III Oncology Study, Advancing Technological Reforms in Cloud-Based Electronic Data Capture, Randomization, and Supply Chain Management
Medidata and Validic, a leading digital health platform in the healthcare industry, announce a partnership to advance connectivity and innovation in clinical research by expanding access to patient-generated data from consumer-grade and medical-grade mobile health devices and applications;
R&G PharmaStudies Co., Ltd. Expands the Use of Medidata Cloud in Streamlining Clinical Trial Operations;
Medidata Cloud Supports U.S. Government Research on Reducing Drug Development Costs
The success of the aforementioned collaboration is attributable to Medidata’s unique core competencies. Medidata’s flagship offering is its Cloud Platform, along with its integrated data collection and processing system. This SaaS software enables any interested party to record, track, manage, and provide feedback on clinical trials, thereby transforming how pharmaceutical companies, healthcare institutions, and government agencies conduct such trials. It allows them to identify and rectify loopholes in trials more efficiently and at lower cost. As a result, Medidata has grown into a publicly listed company with 1,000 employees and annual sales of $277 million.
Introduction to the Core Creative Team
Glen de Vries is the Founder and President of Medidata Solutions, responsible for setting corporate strategy and planning future prospects, while also holding patents in the fields of clinical medicine and software development.
Glen de Vries graduated from Carnegie Mellon University (CMU) and previously served as President of OceanTek and Director of the Columbia University Medical Center.
Mike CaponeYesChief Operating Officer of Medidata Solutions, responsible for product research and development, professional services, market research, and daily operations at Medidata.
Mike Capone graduated from Dickinson College and holds an MBA in Finance from Pace University. He previously worked at ADP, where he served as Senior Vice President and Chief Information Officer.
On April 4, 2016, Medidata announced the acquisition of Intelemage, a global leader in medical data visualization, with the transaction expected to close in the second quarter of 2016. This acquisition is poised to enhance the performance of Medidata’s SaaS platform, positioning it as the world’s most accurate and fastest platform for capturing, processing, and analyzing medical data.